Surrozen SRZN

Surrozen, Inc./DE · Nasdaq · Biological Products, (No Diagnostic Substances)

$30.35+2.78%close on Oct. 28, 2026 · volume 143K · Yahoo Finance

Price, last 47 sessions

$20.00$25.00$30.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $33.68 · low $16.16 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
July 22, 2026TCG Crossover GP II LLC
with TCG Crossover Fund II L.P., TCG Crossover GP III LLC, TCG Crossover Fund III L.P., Chen-Ming Yu
10% owner · indirect
Sold325,000$21.25$6.91 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 15 →
  • 4Oct. 22, 2026, 4:48 p.m. ETView on SEC.gov
  • SCHEDULE 13D/AOct. 22, 2026, 4:45 p.m. ETView on SEC.gov
  • 4Oct. 22, 2026, 4:45 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 5:04 p.m. ETView on SEC.gov

    Results of operations and financial condition · Unregistered sales of equity securities · Financial statements and exhibits

    AI summary, unreviewedSurrozen Closes Second Tranche of March 2025 Private Placement for $95.1 Million Gross, Extending Cash Runway into 2029

  • SCHEDULE 13G/AOct. 7, 2026, 7:06 p.m. ETView on SEC.gov
  • 8-KOct. 2, 2026, 8:05 a.m. ETView on SEC.gov

    Other events

  • SCHEDULE 13GOct. 1, 2026, 4:59 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 4:05 p.m. ETView on SEC.gov